Phinomics
11 employees on LinkedIn · 1 known investors
Phinomics is a cancer drug discovery platform that captures extrachromosomal circular DNA (the "Circulome") at high resolution from matched tumor and normal patient samples, integrating it with DNA, RNA, epigenetics, and proteomics into a multi-omic knowledge graph. It applies explainable AI to this data to identify novel therapeutic targets, resistance mechanisms, and patient stratification biomarkers for oncology therapeutics development.
Founders & leadership
MS
Massa ShourainFounder, CEO, CSO
SL
Stephen LeveneFounder, CTO
Investors · 1
Frequently asked questions
- What does Phinomics do?
- Phinomics is a cancer drug discovery platform that captures extrachromosomal circular DNA (the "Circulome") at high resolution from matched tumor and normal patient samples, integrating it with DNA, RNA, epigenetics, and proteomics into a multi-omic knowledge graph. It applies explainable AI to this data to identify novel therapeutic targets, resistance mechanisms, and patient stratification biomarkers for oncology therapeutics development.
- Who founded Phinomics?
- Phinomics was founded by Massa Shoura, Stephen Levene.
- Who are Phinomics's investors?
- Phinomics's investors include Silicon Catalyst.